cefoperazone has been researched along with Disbacteriosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Antonopoulos, DA; Chang, EB; Frith, M; Kennedy, M; Koval, JC; Lee, STM; Leone, V; Miyoshi, J; Miyoshi, S; Puertolas, M | 1 |
Diener, C; Erdman, SE; Gibbons, SM; Hoge, ACH; Kearney, SM; Kusebauch, U; Moritz, RL; Patwardhan, S | 1 |
An, Z; Fan, B; Liu, M; Luo, J; Wang, L; Wang, Z; Zhao, X | 1 |
Kim, YG; Núñez, G; Shibuya, A; Totsuka, N; Udayanga, KG; Weinberg, JB | 1 |
4 other study(ies) available for cefoperazone and Disbacteriosis
Article | Year |
---|---|
Metagenomic Alterations in Gut Microbiota Precede and Predict Onset of Colitis in the IL10 Gene-Deficient Murine Model.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Colitis; Disease Models, Animal; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Humans; Interleukin-10; Intestinal Mucosa; Male; Metagenome; Metagenomics; Mice; Mice, Knockout; Prognosis | 2021 |
Non-responder phenotype reveals apparent microbiome-wide antibiotic tolerance in the murine gut.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Bacteria; Cefoperazone; Drug Tolerance; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Genotype; Intestines; Mice, Inbred C57BL; Phenotype; Seaweed; Time Factors | 2021 |
A comparative study of the effects of different fucoidans on cefoperazone-induced gut microbiota disturbance and intestinal inflammation.
Topics: Animals; Anti-Bacterial Agents; Cecum; Cefoperazone; Cytokines; Dysbiosis; Female; Gastrointestinal Microbiome; Inflammation; Intestinal Mucosa; Intestines; Mice; Mice, Inbred C57BL; Molecular Weight; Polysaccharides; Prebiotics | 2021 |
Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.
Topics: Adoptive Transfer; Ampicillin; Animals; Anti-Bacterial Agents; Aspirin; Candida; Candidiasis; Cefoperazone; Celecoxib; Clindamycin; Cyclooxygenase Inhibitors; Dinoprostone; Dysbiosis; Feces; Gastrointestinal Tract; Inflammation; Lung; Macrophage Activation; Macrophages, Alveolar; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyrazoles; Sulfonamides | 2014 |